Proceedings of the Texas A&M Medical Student Grand Rounds

What’s “Bugging” You? – Investigating the Potential Role of the GI Microbiome in the Association between Appendectomy and Glucose Intolerance

July 25, 2023 Maya Pimentel

Maya Pimentel

Background: Approximately 462 million people live with type 2 diabetes mellitus (T2D) worldwide.1 Although, once diagnosed, T2D is a lifelong, often progressive illness that requires regular medical evaluation, it is often a preventable condition. Therefore, attention has switched from a prophylactic response to a preventive approach in T2D management. As a result, research is now evaluating other, less obvious risk factors for T2D. One field of growing interest is the relationship between appendectomies, or surgical removals of the appendix, and T2D diagnosis.

Methods:  A database search in PubMed was performed for relationships among the keywords “insulin,” “glucose tolerance,” “insulin tolerance,” “diabetes,” “insulin resistance,” “microbiome,” “appendicitis,” and “short chain fatty acids,” with exclusion criteria of studies published more than five years prior to this review.

Results: In a 2018 clinical study, after reviewing the medical history of 10,954 subjects between the years 1998 and 2013, investigators found a correlation between appendectomy procedures and later onset of T2D.2 Their findings suggested an increased risk of T2D diagnosis among patients under 30 years old who underwent an appendectomy, as compared to control. This finding poses the question: how are the appendix and diabetic glucose intolerance related? Little is known about the function of the appendix. However, growing research suggests that it plays an important role in communicating with the gut microbiome.

Following appendectomy, one significant change in the intestinal microbiome is the loss of short-chain fatty acid (SCFA) producing bacteria in the intestine.3 A cross-sectional study investigated the stool microbiome, via 16S rRNA sequencing, of patients following appendectomy procedure and compared these results to the microbial fingerprints of healthy controls. The results demonstrated a significant decrease in abundance of SCFA producers: Roseburia, Barnesiella, Butyricicoccus, Odoribacter, and Butyricimonas species.

Interestingly, another study found similar microbiome alterations with glucose tolerance. Published in 2020, the study recruited patients and divided them by glucose tolerance as well as diabetic diagnosis and performed 16S rRNA microbial sequencing of stool samples.4 After comparing microbial populations, the study found that patients with impaired glucose tolerance have significantly lower levels of SCFA, particularly butyrate, producers, similar to the appendectomy population from the previously discussed study.

Therefore, the intestinal microbiome may play an intermediate role in the association of appendectomy and T2D diagnosis. However, further research is required to validate the aforementioned hypothesis and better understand the role of the gut in host health.

Conclusion: The shared microbial dysbiosis between patients following appendix removal and patients with diabetes may, with further validation and research, provide a cohesive narrative for the association of T2D onset following appendectomy.

Works Cited:

  1. Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, Al Kaabi J. Epidemiology of Type 2 Diabetes – Global Burden of Disease and Forecasted Trends. J Epidemiol Glob Health. 2020;10(1):107-111. doi:10.2991/jegh.k.191028.001
  2. Lee YM, Kor CT, Zhou D, Lai HC, Chang CC, Ma WL. Impact of age at appendectomy on development of type 2 diabetes: A population-based cohort study. PLoS One. 2018;13(10):e0205502. Published 2018 Oct 16. doi:10.1371/journal.pone.0205502
  3. Cai S, Fan Y, Zhang B, et al. Appendectomy Is Associated With Alteration of Human Gut Bacterial and Fungal Communities. Front Microbiol. 2021;12:724980. Published 2021 Sep 16. doi:10.3389/fmicb.2021.724980
  4. Wu H, Tremaroli V, Schmidt C, et al. The Gut Microbiota in Prediabetes and Diabetes: A Population-Based Cross-Sectional Study. Cell Metab. 2020;32(3):379-390.e3. doi:10.1016/j.cmet.2020.06.011 [study]

 

 

 

 

 

 

 

Engineering Medicine Featured Abstracts Gastroenterology Microbiology
Previous Post

Multiple Sclerosis and the Epstein Barr Virus - Autoimmunity Through Molecular Mimicry of EBNA1 with GlialCAM

Next Post

Identifying Chemical Enhancers for Oncolytic Virotherapy in Treatment of Gliomas

Scientific Editors

Steve A. Maxwell

Executive Editor
Tel: 979-436-0804
smaxwell@medicine.tamhsc.edu

Robin Fuchs-Young

Deputy Editor
Tel: 979-845-5109
fuchs-young@medicine.tamhsc.edu
Administrative Editor

Janis Chmiel

Tel: 979-436-0856
chmiel@medicine.tamhsc.edu
Editorial Office
Tel.: 979-845-2726
Fax: 979-847-9481
chmiel@medicine.tamhsc.edu
Archives
  • July 2026
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • May 2025
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • November 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • August 2022
  • June 2022
  • May 2022
  • August 2021
  • July 2021
  • April 2021
  • October 2020
  • August 2020
  • July 2020
  • August 2019
  • July 2019
  • February 2019
  • July 2018
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • January 2017
Proudly powered by WordPress | Theme: Fmi by Forrss.